Can a single infusion of reprogrammed immune cells quiet lupus kidney disease?
⭐️ CURE ⭐️
Not yet recruiting
This phase 2 trial is testing whether a single infusion of a patient's own genetically modified immune cells, called C-CAR168, can safely and effectively treat lupus nephritis that has not responded to standard therapies. The cells are designed to target and eliminate specific im…
Phase: PHASE2 • Sponsor: AbelZeta Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jul 30, 2026 00:00 UTC